510(k) · Cleared
ClearedBrush Biopsy Set ; Deflectable Brush Biopsy Set
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cook Incorporated · FDX Endoscopic Cytology Brush
Cleared on May 1, 2019 as substantially equivalent to K810372 (Vance Products, Inc., 1981) and 1 other predicate after a 257-day review. Its family tree reaches back 1 generation to 1977.
- Decided
- May 1, 2019
- Review
- 257 days
- Class
- Class II
- Product code
- FDX
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K770913 (1977). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK770913 Urological Biopsy Brush SetCook, Inc. · 1977
- This deviceK182231 Brush Biopsy Set ; Deflectable Brush Biopsy SetCook Incorporated · 2019
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K770913 | Urological Biopsy Brush Set | Cook, Inc. | 1977 | — |
| 0 (this device) | K182231 | Brush Biopsy Set ; Deflectable Brush Biopsy Set | Cook Incorporated | 2019 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1981 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FDX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FDX device
- #1 K250993 Single Use Cytology Brush V (BC-V600P-3010)score 11.7 · 5 generations · no Class I recall
- #2 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K810372 | Vance Deflectable Biopsy Brush SetSummary page 4…FDX Device Class/Classification Panel: Class II, Gastroenterology/Urology Predicate Devices: Primary predicate device: Vance Deflectable Biopsy Brush Set (K810372) Secondary predicate device: Urological Biopsy Brush Set (K770913) Device Description: The Brush Biopsy Set and Deflect… | 1981 |
| * | K770913 | Urological Biopsy Brush SetSummary page 4…ology Predicate Devices: Primary predicate device: Vance Deflectable Biopsy Brush Set (K810372) Secondary predicate device: Urological Biopsy Brush Set (K770913) Device Description: The Brush Biopsy Set and Deflectable Brush Biopsy Set are designed to be used through rigid or flexible e… | 1977 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- None of the 2 ancestors has a recall.
- 1 other device also cites its predicate K810372.
How does its category compare?
All FDX devicesFDX Endoscopic Cytology Brush: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.
FDA decisions per year · FDX
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FDX
144in 2019
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FDX
2in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · FDX
11in 2025
MAUDE reports naming product code FDX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 6 |
| 2008 | 0 | — | 0 | 14 |
| 2009 | 0 | — | 0 | 37 |
| 2010 | 1 | — | 0 | 37 |
| 2011 | 0 | — | 0 | 36 |
| 2012 | 0 | — | 0 | 28 |
| 2013 | 0 | — | 0 | 45 |
| 2014 | 0 | — | 0 | 61 |
| 2015 | 1 | — | 0 | 62 |
| 2016 | 0 | — | 0 | 45 |
| 2017 | 2 | — | 0 | 44 |
| 2018 | 1 | — | 0 | 48 |
| 2019 | 4 | 144 | 0 | 67 |
| 2020 | 0 | — | 0 | 13 |
| 2021 | 0 | — | 1 | 19 |
| 2022 | 1 | — | 2 | 17 |
| 2023 | 0 | — | 0 | 17 |
| 2024 | 0 | — | 0 | 20 |
| 2025 | 1 | — | 0 | 11 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Brush Biopsy Sets are intended to obtain pathology specimens from lesions in the ureter, renal pelvis, infundibula or calyces under direct vision.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K182231 · printed Nov 6, 2026
Cite this page
510(k) Report. “K182231: Brush Biopsy Set ; Deflectable Brush Biopsy Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K182231
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026